Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2478 Views
-
Last post by NHE
-
- 6 Replies
- 7028 Views
-
Last post by ElliotB
-
- 0 Replies
- 1409 Views
-
Last post by NHE
-
- 0 Replies
- 3668 Views
-
Last post by NHE
-
- 1 Replies
- 1105 Views
-
Last post by NHE
-
- 1 Replies
- 1647 Views
-
Last post by NHE
-
- 11 Replies
- 3495 Views
-
Last post by NHE
-
- 0 Replies
- 3382 Views
-
Last post by NHE
-
- 0 Replies
- 1561 Views
-
Last post by NHE